tag:blogger.com,1999:blog-16774010.post114640826672644298..comments2024-01-25T17:58:34.297-05:00Comments on Scott's Web Log: Yet Another "Potential" Cure For Type 1?Scott Shttp://www.blogger.com/profile/03286529314567223617noreply@blogger.comBlogger4125tag:blogger.com,1999:blog-16774010.post-1146837235368486412006-05-05T09:53:00.000-04:002006-05-05T09:53:00.000-04:00That's one reason the MGH research has become so i...That's one reason the MGH research has become so incredibly popular, because they plan to begin testing on longstanding T1 patients, and the plan is to begin later this year. Given that the confirming research on mice was successful, but less successful than Dr. Faustman's initial results, there is still potential there, but people need to be realistic about the potential, but every contribution to science is important.Scott Shttps://www.blogger.com/profile/03286529314567223617noreply@blogger.comtag:blogger.com,1999:blog-16774010.post-1146792657687325232006-05-04T21:30:00.000-04:002006-05-04T21:30:00.000-04:00The problem with the "near future" is that it is a...The problem with the "near future" is that it is all relative depending on what mark one is standing on in the line continuum to progress in medical research & benefit.<BR/>Thus the testing in the near future can be in 5 years or 200 years. There are too many variables including money, research priorities, politics, and above all intelligence.BetterCellhttps://www.blogger.com/profile/13667917240368089110noreply@blogger.comtag:blogger.com,1999:blog-16774010.post-1146790860411652002006-05-04T21:01:00.000-04:002006-05-04T21:01:00.000-04:00Newly diagnosed patients still maintain measurable...Newly diagnosed patients still maintain measurable endogenous insulin production, therefore most of the trials revolve around preserving the remaining beta cell functionality. However, as the results from the 2005 ADA Scientific Sessions demonstrated "sustained islet turnover" even among longstanding type 1 patients (some in that study had it as long as 60 years). Hopefully, they will begin testing on long-standing T1DM patients in the near future.Scott Shttps://www.blogger.com/profile/03286529314567223617noreply@blogger.comtag:blogger.com,1999:blog-16774010.post-1146779076997028452006-05-04T17:44:00.000-04:002006-05-04T17:44:00.000-04:00Hello Scott......This is a step in the right direc...Hello Scott......This is a step in the right direction regarding immune modulation eventhough it only (at this time) applies to "newly acquired T1DM". It is the rest of us who are in need of a way to have insulin being produced without an overzealous immune system. I have also posted a response to your reply on my site.BetterCellhttps://www.blogger.com/profile/13667917240368089110noreply@blogger.com